Sue Macleman Insider Profile

4 Followers
Sue Macleman, Director at Oventus Medical Ltd., holds 3.54M shares in Tali Digital (Ticker: DE:UV7), holds 224.42K shares in Oventus Medical Ltd. (Ticker: AU:OVN), holds 78.07K shares in Anatara Lifesciences Ltd (Ticker: AU:ANR). Most recently, Sue Macleman Bought ― shares of Tali Digital on Jul 07, 2022 for an estimated value of 28.73K.
tipranks
Sue  Macleman

Sue Macleman
Oventus Medical Ltd. (OVN)
Director

Ranked #67,437 out of 99,218 Corporate Insiders

Profitable Transactions

40%
2 out of 5 Profitable Transactions

Average Return

-10.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

€60K
92.12%
7.88%
A breakdown of Sue Macleman's holdings

Insider Roles

Tali Digital
(UV7)
Director
Anatara Lifesciences Ltd
(ANR)
Director
Roles that Sue Macleman holds in companies

Most Profitable Insider Trade

Stock:
Oventus Medical Ltd.
(OVN)
Rating:Informative Buy
Date:Mar 11, 2019 - Mar 11, 2020
Return:+55.70%
The most profitable trade made by Sue Macleman

Sue Macleman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
OVN
Oventus Medical Ltd.
Sep 16, 2021
Informative Buy
10.13K
AU$4.49K
Anatara Lifesciences Ltd
Sep 13, 2021
Director
Informative Buy
5.13K
AU$4.84K
Tali Digital
Jul 07, 2022
Director
Informative Buy
28.73K
€56.58K
List of latest transactions for each holding click on a transaction to see Sue Macleman's performance on stock

Sue Macleman insider profile FAQ

What is the percentage of profitable transactions made by Sue Macleman?
The percentage of profitable transactions made by Sue Macleman is 40%.
    What is the average return per transaction made by Sue Macleman?
    The average return per transaction made by Sue Macleman is -10.80%.
      What stocks does Sue Macleman hold?
      Sue Macleman holds: AU:OVN, AU:ANR, DE:UV7 stocks.
        What was Sue Macleman’s latest transaction?
        Sue Macleman latest transaction was an Informative Buy of €28.73K.
          What was Sue Macleman's most profitable transaction?
          Sue Macleman’s most profitable transaction was an Informative Buy of AU:OVN stock on March 11, 2019. The return on the trade was 55.70%.
            What is Sue Macleman's role in Oventus Medical Ltd.?
            Sue Macleman's role in Oventus Medical Ltd. is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.